A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/13/2011	US20110251144 Molecular modulators of the wnt/beta-catenin pathway
10/13/2011	US20110251138 Lipoic acid metabolite conjugate: preparation and their therapeutic effect
10/13/2011	US20110251133 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
10/13/2011	US20110251132 Treatment with a pharmaceutical composition comprising manf2 nucleic acid
10/13/2011	US20110251131 Deuterated 2-amino-3-hydroxypropanoic acid derivatives
10/13/2011	US20110251121 Use of cysteine-rich whey derived protein in patients receiving chemotherapy and/or radiotherapy to improve patient survival
10/13/2011	US20110250300 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
10/13/2011	US20110250284 Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
10/13/2011	US20110250282 Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
10/13/2011	US20110250272 Solid, orodispersible and/or dispersible composition, without an excipient of known effect and its process of preparation
10/13/2011	US20110250261 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
10/13/2011	US20110250260 Inhibition of brain enzymes inolved in cerebral amyloid angiopathy and macular degeneration
10/13/2011	US20110250243 Nanoparticle compositions
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250236 Stem cells derived from the carotid body and uses thereof
10/13/2011	US20110250217 Methods and compositions for eliciting an amyloid-selective immune response
10/13/2011	US20110250215 Structurally-related relaxin-fusion proteins with extended in vivo half-lives
10/13/2011	US20110250214 Drug delivery system toward demyelinating lesion and biochemical marker of demyelinating lesion
10/13/2011	US20110250212 Therapy procedure for drug delivery for trigeminal pain
10/13/2011	US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011	US20110250208 Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor
10/13/2011	US20110250206 Markers for determination of patient responsiveness
10/13/2011	US20110250201 Antagonists of il-6 to raise albumin and/or lower crp
10/13/2011	US20110250200 Soluble lymphotoxin-beta receptor fusion protein and methods for inhibiting lymphotoxin beta-receptor signaling
10/13/2011	US20110250197 Pharmaceutical combination
10/13/2011	US20110250193 Composition comprising expression or activity inhibitors of ninjurin1 for the prevention and treatment of inflammatory disease
10/13/2011	US20110250183 Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction
10/13/2011	US20110250150 Multi-Part Kit Comprising A Chewing Gum And Further A Flavor Containing Formulation
10/13/2011	US20110250135 Piperazine Derivatives for Binding and Imaging Amyloid Plaques and Their Use
10/13/2011	US20110250134 Sustained release nitric oxide from long lived circulating nanoparticles
10/13/2011	US20110250130 Tnf-alpha binding proteins
10/13/2011	US20110250129 Bioluminescence imaging-based screening assay and inhibitors of abcg2
10/13/2011	CA2829790A1 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	CA2795877A1 Novel sultam compounds
10/13/2011	CA2795866A1 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
10/13/2011	CA2795726A1 Treatment of ataxia telangiectasia
10/13/2011	CA2793709A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	CA2788762A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/12/2011	EP2374871A1 Pluripotent stem cells, method for preparation thereof and uses thereof
10/12/2011	EP2374796A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders
10/12/2011	EP2374792A1 N-substituted benzene sulfonamides
10/12/2011	EP2374790A1 Biphenylacetamide derivative
10/12/2011	EP2374508A1 Combination of angiotension receptor blockers (ARB) and NSAIDs for use in ameliorating cachexia
10/12/2011	EP2374459A1 Treatment for neurological and mental disorders
10/12/2011	EP2374458A1 Combination of an ACE inhibitor and an NSAID for use in ameliorating cachexia/SIRS
10/12/2011	EP2374455A2 Modulators of muscarinic receptors
10/12/2011	EP2374453A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
10/12/2011	EP2373659A1 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/12/2011	EP2373652A1 Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
10/12/2011	EP2373651A1 Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
10/12/2011	EP2373649A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
10/12/2011	EP2373641A1 Pyridazinone derivatives
10/12/2011	EP2373639A1 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives
10/12/2011	EP2373627A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
10/12/2011	EP2373605A1 Compounds for use in the treatment of pain
10/12/2011	EP2373328A2 Stroke-generated angiogenesis enhancers and uses thereof
10/12/2011	EP2373314A1 Use of eltoprazine for the treatment of l-dopa-induced dyskinesia
10/12/2011	EP2051991B1 Cardioprotective compounds
10/12/2011	EP1893191B1 Medicinal acidic cannabinoids
10/12/2011	EP1853266B1 2s,4r ketoconazole for treating diabetes, metabolic syndrome and other conditions
10/12/2011	EP1656349B1 Cyclopropyl derivatives as nk3 receptor antagonists
10/12/2011	EP1534285B1 Selective phosphodiesterase 9a inhibitors as medicaments for improving cognitive processes
10/12/2011	EP1448995B9 Assay for screening candidate drugs for the treatment of inflammatory diseases
10/12/2011	EP1294377B1 Methods and compositions for the treatment of alcoholism and alcohol dependence
10/12/2011	CN1981761B Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
10/12/2011	CN102216318A Antioxidant
10/12/2011	CN102216304A Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
10/12/2011	CN102216295A 8-azabicyclo [3.2.1]oct-2-ene derivatives and their use as mono-amine neurotransmitter re-uptake inhibitors
10/12/2011	CN102216291A Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
10/12/2011	CN102216289A Nicotinic acetylcholine receptor ligands and the uses thereof
10/12/2011	CN102216283A Quinazoline derivatives as NK3 receptor antagonists
10/12/2011	CN102216282A Aryl piperazine and their use as alpha2c antagonists
10/12/2011	CN102216272A 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
10/12/2011	CN102216271A Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
10/12/2011	CN102216257A GABA conjugates and methods of use thereof
10/12/2011	CN102215868A Methods for treating progressive multiple sclerosis
10/12/2011	CN102215860A Methods of treating cognitive impairment
10/12/2011	CN102215857A Pharmaceutical composition containing ginger extract or shogaol
10/12/2011	CN102215845A Solid state forms of a pharmaceutical
10/12/2011	CN102215822A Novel composition based on gamma-hydroxybutyric acid
10/12/2011	CN102212447A Health-care wine
10/12/2011	CN102212116A Acetylcholine receptor mediated brain-targeted polypeptide and application thereof
10/12/2011	CN102212111A Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
10/12/2011	CN102212093A Flavonoid glycoside compounds, method for preparing same and application
10/12/2011	CN102212058A Single composite medicament (chiral nitrogenous heterocyclic ester) and synthesis method thereof as well as application of chiral nitrogenous heterocyclic ester in preparing low-toxicity CB1 receptor inhibitor
10/12/2011	CN102212014A Crystal form of O-demethyl-venlafaxine glutamate, preparation method and medicinal application thereof
10/12/2011	CN102212008A Tanshinol ligustrazine derivative and preparation method and application thereof
10/12/2011	CN102210850A Method for increasing expression of deacetylase
10/12/2011	CN102210838A Medicinal composition for strengthening immunity and improving human body condition
10/12/2011	CN102210827A Traditional Chinese medicine for stopping smoking
10/12/2011	CN102210800A New application of citron daylily and citron daylily general flavone
10/12/2011	CN102210795A Traditional Chinese medicine composition for treating various pains
10/12/2011	CN102210790A Compound agilawood essential oil for releasing tension headache
10/12/2011	CN102210789A Agilawood compound essential oil capable of improving sleeping
10/12/2011	CN102210766A Traditional Chinese medicine composition for treating mental anxiety
10/12/2011	CN102210759A Application of Chinese medicinal component in preparation of nitric oxide donor medicament
10/12/2011	CN102210752A Application of suspension and extract of fleece flower root or prepared fleece flower root in preparation of medicaments for treating depression
10/12/2011	CN102210738A Preparation method of total flavonoids in albizia julibrissin durazz and medicinal composition thereof
10/12/2011	CN102210732A Method for extracting panax notoginseng saponins from fresh panax notoginseng by enzyme treatment
10/12/2011	CN102210717A Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains

1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 1833